Quick Answer
Lexaria Bioscience Corp. reported Total Assets of $4.18 million for the year ending 2025.
- Lexaria Bioscience Corp. showed a decrease of -52.9% in Total Assets from 2024 to 2025.
- This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on November 28, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $3.86 million | Q1 2012: $4.23 million | Q2 2012: $4.13 million | Q3 2012: $4.22 million | Q1 2013: $3.92 million | Q2 2013: $3.80 million | Q3 2013: $3.68 million | Q4 2013: $3.57 million | Q1 2014: $3.56 million | Q2 2014: $4.84 million | Q3 2014: $4.57 million | Q4 2014: $2.25 million | Q1 2015: $1.21 million | Q2 2015: $1.20 million | Q4 2015: $496.1 thousand | Q1 2016: $389.4 thousand | Q2 2016: $331.3 thousand | Q4 2016: $1.14 million | Q1 2017: $869.1 thousand | Q2 2017: $3.14 million | Q4 2017: $2.50 million | Q1 2018: $2.84 million | Q2 2018: $2.71 million | Q4 2018: $3.54 million | Q1 2019: $4.27 million | Q2 2019: $3.46 million | Q4 2019: $2.75 million | Q1 2020: $1.99 million | Q2 2020: $3.32 million | Q4 2020: $2.17 million | Q1 2021: $12.17 million | Q2 2021: $10.55 million | Q4 2021: $11.75 million | Q1 2022: $11.41 million | Q2 2022: $9.14 million | Q4 2022: $6.21 million | Q1 2023: $4.85 million | Q2 2023: $5.24 million | Q4 2023: $3.63 million | Q1 2024: $6.35 million | Q2 2024: $10.02 million | Q4 2024: $9.79 million | Q1 2025: $8.68 million | Q2 2025: $6.74 million | Q3 2025: $4.18 million | Q4 2025: $6.05 million.
- Over the full 16 years of available data (2010 to 2025), Lexaria Bioscience Corp.'s Total Assets has grown by 27.4%.
- Historical annual values: Fiscal year 2025: $4.18 million | Fiscal year 2024: $8.87 million | Fiscal year 2023: $3.08 million | Fiscal year 2022: $7.83 million | Fiscal year 2021: $13.27 million | Fiscal year 2020: $2.83 million | Fiscal year 2019: $2.68 million | Fiscal year 2018: $2.43 million | Fiscal year 2017: $2.86 million | Fiscal year 2016: $566.6 thousand | Fiscal year 2015: $711.7 thousand | Fiscal year 2014: $2.64 million | Fiscal year 2013: $3.57 million | Fiscal year 2012: $4.19 million | Fiscal year 2011: $4.34 million | Fiscal year 2010: $3.28 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: